Evidence map›Paper›PMID 23623336›Full record

ReviewCurrent opinion in structural biology2013

Expression of recombinant glycoproteins in mammalian cells: towards an integrative approach to structural biology.

A Radu Aricescu, Raymond J Owens

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in structural biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. GABAMolecular cell · 2025
    Article
  3. Glycoproteins in Viruses.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Structural basis for GABANature structural & molecular biology · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

A Radu AricescuDivision of Structural Biology, University of Oxford, Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford OX3 7BN, UK. radu@strubi.ox.ac.uk
Raymond J Owens
Rutherford Appleton Laboratory · GBUniversity of Oxford · GB

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council G0700232Medical Research Council MR/K018779/1Medical Research Council MR/L009609/1Wellcome Trust 090532
6 · The paper itself

Abstract

Mammalian cells are rapidly becoming the system of choice for the production of recombinant glycoproteins for structural biology applications. Their use has enabled the structural investigation of a whole new set of targets including large, multi-domain and highly glycosylated eukaryotic cell surface receptors and their supra-molecular assemblies. We summarize the technical advances that have been made in mammalian expression technology and highlight some of the structural insights that have been obtained using these methods. Looking forward, it is clear that mammalian cell expression will provide exciting and unique opportunities for an integrative approach to the structural study of proteins, especially of human origin and medically relevant, by bridging the gap between the purified state and the cellular context.

Indexed as

AnimalsCell LineCHO CellsCricetulusGene ExpressionGlycoproteinsGlycosylationHEK293 CellsHumansMammalsMolecular BiologyProtein ConformationReceptors, Cell SurfaceRecombinant ProteinsSignal TransductionStaining and LabelingGlycoproteinsReceptors, Cell SurfaceRecombinant Proteins

Identifiers

PMID23623336
PMCPMC4757734
OpenAlexW2117967265

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.